🔴 Recursion Pharmaceuticals is trading 6.7% down today after pricing $200 million offering below prior close

Recursion Pharmaceuticals is trading at $3.88, down 6.73%, as reports linked the decline to its discounted share offering.

• The company priced a $200 million offering of 61.54 million shares at $3.25 each, below the prior close.
• Recursion said the capital raise is expected to extend its cash runway into 2029.
• Positive clinical updates and a $10 million Sanofi milestone were also announced October 15.